An 12-week, Randomised, Parallel-group, Phase III Study Comparing the Efficacy of Once-daily Formoterol/Budesonide Turbuhaler 4.5/160 µg and Twice-daily Budesonide Giona Easyhaler 200 µg During Step-down in Well Controlled Asthma

Trial Profile

An 12-week, Randomised, Parallel-group, Phase III Study Comparing the Efficacy of Once-daily Formoterol/Budesonide Turbuhaler 4.5/160 µg and Twice-daily Budesonide Giona Easyhaler 200 µg During Step-down in Well Controlled Asthma

Completed
Phase of Trial: Phase III

Latest Information Update: 21 Apr 2017

At a glance

  • Drugs Budesonide/formoterol (Primary) ; Budesonide
  • Indications Asthma
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 Dec 2016 Status changed from recruiting to completed.
    • 04 Apr 2016 New trial record
    • 03 Apr 2016 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top